How Peptide Purity Is Measured

Purity is the figure most often quoted for a research peptide, and the one most often asked to carry more weight than it can bear. A percentage on a listing tells you something specific and fairly narrow. On its own it does not tell you the material is the compound you ordered, and it does not tell you how much of that compound is in the vial.

Three separate questions sit behind a complete analytical picture: what is it, how much of the sample is it, and how much is there. Each is answered by a different measurement.

Purity versus identity

The distinction is easy to state and easy to lose track of.

Identity asks whether the material is the compound named on the label. Is this actually BPC-157, or something else entirely?

Purity asks what proportion of the analysed sample consists of that main component rather than related substances. Given that it is the right molecule, how much of what was measured is that molecule?

The order matters. A purity result assumes an identity the purity method itself did not establish. A material could return an impressive chromatogram — one clean, dominant peak, almost nothing else — while being the wrong peptide entirely.

Regulatory frameworks treat the two as separate specification attributes for exactly this reason, alongside quantity as a third.[1] A listing that advertises a percentage without indicating how identity was confirmed has left the more basic question unanswered.

The role of HPLC

High-performance liquid chromatography is the standard method for assessing peptide purity. The sample is carried through a column packed with a stationary phase, and its components separate according to how strongly they interact with it. Each emerges at a characteristic retention time and passes a UV detector set where the peptide bond absorbs.

The output is a chromatogram: a series of peaks plotted against time. Purity is calculated by area normalisation — the integrated area of the main peak divided by the total integrated area of all peaks, expressed as a percentage.[2],[3]

The word doing quiet work in that definition is relative. The figure describes the main peak's share of what the detector registered. Material that does not absorb at the detection wavelength — salts, residual water, counterions retained from purification, certain solvents — contributes little or nothing to the total and therefore does not reduce the percentage, even though it occupies mass in the vial.

Method conditions also shape the result. Column chemistry, gradient profile, and detection wavelength all affect how well closely related substances resolve from the main peak, so two laboratories using different methods can legitimately report different numbers. A fuller treatment is in what is HPLC testing.

The role of mass spectrometry

Mass spectrometry supplies the identity confirmation that chromatography cannot.

The sample is ionised and the instrument measures the mass-to-charge ratio of the resulting ions. From this an observed molecular mass is derived. Because a peptide's amino acid sequence determines its molecular formula, a theoretical mass can be calculated in advance. The observed and theoretical values are compared.

Agreement within the method's tolerance is strong evidence the material is the expected compound. A discrepancy is diagnostic rather than merely negative — a mass sixteen units higher than expected commonly indicates oxidation, and a deficit matching a known residue points to a deletion sequence.

The two techniques are frequently coupled, with the chromatograph feeding eluent directly into the mass spectrometer. That produces mass information for individual peaks, allowing impurities to be characterised rather than simply counted.

Why quantity is a separate measurement

Neither purity nor identity establishes how much peptide a vial contains.

Consider a vial labelled 10 mg with a report showing 99% purity. Both statements can be accurate while the vial holds meaningfully less than 10 mg of peptide. Purity describes the composition of whatever was analysed, not the quantity dispensed into the container.

Lyophilised peptides are rarely pure peptide by mass. The dried solid also contains counterions from purification — most peptides are produced as trifluoroacetate salts, and TFA cannot be entirely removed because it binds to the N-terminus and to basic side chains — along with residual moisture.[3] The industry term for the peptide fraction is net peptide content: the percentage of peptide relative to non-peptidic material. For research-grade peptides it commonly falls between 60% and 85%.[4]

Net peptide content and purity are not the same measurement, and a high purity figure does not imply a high net peptide content. A peptide rich in arginine or lysine forms more salt and will show a lower net peptide content even when it is extremely pure.[3]

Quantity is therefore determined by its own methods. Fill weight is controlled gravimetrically during dispensing. Water content is measured by Karl Fischer titration and residual solvents by gas chromatography. Where actual peptide content is required, quantitative amino acid analysis or elemental nitrogen determination is used — approaches that measure the peptide itself rather than the mass of the solid it sits in.[3],[5]

Three questions, three answers. Identity from mass spectrometry, purity from chromatography, quantity from a content or fill measurement. A report addressing only one is incomplete by design, not by oversight.

Why the laboratory report matters

A purity figure reproduced on a product page is a claim. The report behind it is the evidence, and it carries context the number cannot.

A report names the laboratory, which matters because independent testing removes the supplier from the position of grading its own work. It records when the analysis took place, allowing the result to be assessed against the material's age. It sets out the method, which determines how the figure should be read and whether two results are comparable. And it shows the underlying data rather than only the conclusion.

Purity also varies between batches, so a report tied to a specific lot says more than a general claim.[3] Guidance on the fields found on these documents is in understanding certificates of analysis.

Peptiva's ≥99% release standard

Peptiva applies a release standard of ≥99% purity as determined by HPLC. Material not meeting that threshold is not released for supply.

Two points about the scope of that standard. It is a purity criterion, expressed on the relative, area-normalised basis described above. And it is a release criterion — it applies at the point material enters supply, which is why analysis dates and appropriate storage remain relevant afterwards.

Analytical reports held for Peptiva material are published on the Test Results page so that the reasoning behind the figure can be examined directly.

All products supplied by Peptiva are intended strictly for in vitro research and laboratory use. They are not for human or animal consumption, nor for diagnostic, therapeutic, or medicinal purposes. This article is provided as general analytical background and is not laboratory, medical, or regulatory advice.